Egberg Louise, Mattiasson Anne-Cathrine, Ljungström Karl-Gösta, Styrud Johan
Sophiahemmet University College, Stockholm, Sweden.
J Vasc Nurs. 2010 Jun;28(2):72-7. doi: 10.1016/j.jvn.2010.02.001.
Measuring Health Related Quality of Life has become more and more important in evaluating patients with peripheral arterial disease. This prospective longitudinal survey aimed to investigate health related quality of life over time in patients with peripheral arterial disease (PAD) undergoing percutaneous transluminal angioplasty (PTA) between December 2005 and June 2008. Health Related Quality of life was assessed using the Claudication Scale (CLAU-S) and EQ5D and the Sense of Coherence Scale was used to estimate the patients' sense of coherence. The findings of this study shows that the total CLAU-S score was improved both at one-month follow-up (p < 0.0001) and one-year follow-up (p < 0.0001) compared to baseline. There were significant differences regarding all five dimensions: every day life, pain, social life, illness-specific fears and psychological wellbeing. The EQ5D computed by index improved significantly both at one-month follow-up (p = 0.0006) and one-year follow-up (p = 0.0019) compared to baseline. Differences were found between the groups with low and moderate sense of coherence (p = 0.0169) as well as between the groups with low and high sense of coherence (p = 0.0208) regarding health related quality of life (HRQoL). This study showed that PTA improves HRQoL among individuals suffering from PAD and that the effect is sustainable over time. For more accurate results, a disease-specific instrument should be used to evaluate HRQoL.
在评估外周动脉疾病患者时,测量健康相关生活质量变得越来越重要。这项前瞻性纵向调查旨在研究2005年12月至2008年6月期间接受经皮腔内血管成形术(PTA)的外周动脉疾病(PAD)患者随时间推移的健康相关生活质量。使用跛行量表(CLAU-S)和EQ5D评估健康相关生活质量,并使用连贯感量表来评估患者的连贯感。本研究结果表明,与基线相比,在1个月随访时(p < 0.0001)和1年随访时(p < 0.0001),CLAU-S总分均有所改善。在所有五个维度上存在显著差异:日常生活、疼痛、社交生活、疾病特异性恐惧和心理健康。与基线相比,通过指数计算的EQ5D在1个月随访时(p = 0.0006)和1年随访时(p = 0.0019)均有显著改善。在健康相关生活质量(HRQoL)方面,低连贯感组与中等连贯感组之间(p = 0.0169)以及低连贯感组与高连贯感组之间(p = 0.0208)存在差异。本研究表明,PTA可改善PAD患者的HRQoL,且这种效果随时间可持续。为了获得更准确的结果,应使用特定疾病的工具来评估HRQoL。